From BMI to BCP (Live Webinar, June 21 @11am EDT): Body Composition Profiling with MRI for Metabolic Disease Management, Health Risks & Healthy Lifestyle Choices

MEDIA ANNOUNCEMENT: TUESDAY, JUNE 21, 2022 @ 11:00 AM EDT Live Webinar

  • Register to participate and ask your questions during the Q&A session at the end of the webinar.
  • Event By AMRA Medical is a digital health company at the forefront of medical imaging and precision medicine. The company has developed a new global standard in body composition analysis, delivering multiple fat and muscle biomarkers with unrivaled accuracy and precision – all from a rapid whole-body MRI scan. AMRA offers medical device and medical research services to support transformative care and vital decision-making, from clinical research to clinical care.
  • Speakers (See Bios Below)
    • Carla Prado, PhD, RD, Professor of Human Nutrition, University of Alberta
    • Ian J. Neeland, MD, Director of Cardiovascular Prevention and Co-Director of the Center for Integrated and Novel Approaches in Vascular-Metabolic Disease, University Hospitals; Associate Professor of Medicine, Case Western Reserve University​​
    • Mikael F. Forsgren, PhD, Senior Scientist, Liver Disease Lead Scientist, AMRA Medical

In the search to understand metabolic disease, prevention and treatments, people are often broadly categorized using relatively crude tools. This removes the individualized perspective. For example, obesity is commonly described using BMI (body mass index – weight in kg / height in m2), and individuals are placed in one of five categories ranging from underweight to obesity. However, the health risks related to obesity are more closely linked with body composition — which is the amount of muscle and fat in the body — than with generalized anthropometric measurements, such as body weight, BMI and waist circumference. The use of such broad, discrete categories like obesity, overweight, normal weight and underweight, or even high liver fat / low liver fat, to describe individuals should be questioned. Such categorizations run the risk of grouping individuals with little resemblance to one another, lacking both accuracy and precision for appropriate metabolic disease identification and management. In this webinar, the speakers introduce body composition profiling with magnetic resonance imaging (MRI) as an effective tool to manage metabolic disease state.

Join this webinar’s speakers to gain insights into body composition profiling with MRI, how such measurements have been used in recent research and the recent advancements that have made MRI-based body composition profiling available for clinical use nowadays:

  • Carla Prado, PhD, RD, Professor of Human Nutrition, University of Alberta
  • Ian J. Neeland, MD, Director of Cardiovascular Prevention and Co-Director of the Center for Integrated and Novel Approaches in Vascular-Metabolic Disease, University Hospitals; Associate Professor of Medicine, Case Western Reserve University​​
  • Mikael F. Forsgren, PhD, Senior Scientist, Liver Disease Lead Scientist, AMRA Medical

WHAT YOU WILL LEARN

  • The impact of different body composition profiles on metabolic health, disease risk and metabolic disease treatment and development
  • How body composition can be used to guide treatment

To read more about the webinar From BMI to BCP: Body Composition Profiling with MRI for Metabolic Disease Management, Health Risks & Healthy Lifestyle Choices and the speakers visit the webinar page.

Register to participate and ask your questions during the Q&A session at the end of the webinar.

Visit AMRA MEDICAL website to read more or contact our BD Team at info@amramedical.com

Web Site: http://www.amramedical.com/

Speakers

Carla Prado, PhD, RD, Professor of Human Nutrition, University of Alberta, Canada

Dr. Carla Prado is a Professor at the University of Alberta in Canada and a Campus Alberta Innovate Program (CAIP) chair in nutrition, food and health. She is also the Director of the Human Nutrition Research Unit. She is an expert in assessing nutritional status through the precise measurement of body composition and energy metabolism.

The focus of her current research program is to develop targeted nutrition interventions for the prevention and treatment of low muscle mass in patients with cancer. She is currently the Principal Investigator for three clinical trials investigating the impact of nutrition intervention on body composition and health.

She is an editorial board member of Clinical Nutrition, the Journal of Cachexia, Sarcopenia and Muscle and Current Opinion in Clinical Nutrition and Metabolic Care.

Dr. Prado is a past recipient of Canada’s Top 40 Under 40, an award that celebrates exceptional young Canadian leaders of all sectors, and she was recently inducted into the Royal Society of Canada, the highest academic honor in her country.

Ian J. Neeland, MD, Director of Cardiovascular Prevention and Co-Director of the Center for Integrated and Novel Approaches in Vascular-Metabolic Disease, University Hospitals; Associate Professor of Medicine, Case Western Reserve University

Ian J. Neeland, MD, is Director of the University Hospitals Center for Cardiovascular Prevention, Director of the Translational Science Unit, and Co-Director of the Center for Integrated and Novel Approaches in Vascular-Metabolic Disease (CINEMA program) for University Hospitals Harrington Heart & Vascular Institute and Associate Professor of Medicine at Case Western Reserve University School of Medicine in Cleveland, Ohio. He is a General and Preventive Cardiologist with special expertise in obesity, diabetes and prevention of cardiovascular disease.

Dr. Neeland is a Fellow of the American Heart Association and American College of Cardiology and serves on several national committees with the American Heart Association. He is an active Clinical and Translational Investigator with funding from the National Institutes of Health and industry. He has published over 110 scholarly articles and delivered a number of national, international and regionally invited lectures. He is a reviewer for many respected journals, including Circulation, for which he currently serves as an Associate Editor and Section Editor for Bridging Disciplines.

Mikael F. Forsgren, PhD, Senior Scientist, Liver Disease Lead Scientist, AMRA Medical

Mikael Forsgren is the Lead Scientist for liver diseases at AMRA Medical with the responsibility of developing and leading liver disease application projects. He has been involved in liver-related research using magnetic resonance (MR) imaging and spectroscopy since 2009 — both in academia and industry. He has a MSc in biotechnology and PhD in medical sciences. In his doctoral thesis he explored MR methods to replace the liver needle biopsy and quantify liver function. In addition to exploring body composition in liver diseases, he has applied his MR expertise to assess body composition in COPD, fibromyalgia syndrome and in general populations. Prior to joining AMRA in 2017 he worked as a consultant for Wolfram MathCore, where he collaborated with several pharma companies, academic institutions and the US Food and Drug Administration. He currently holds an adjunct position at Linköping University and is a member of the university’s Center for Medical Image Science and Visualization.


DISCLAIMER AND USE: Concierge Medicine Today, LLC. Is The Industry Physician News & Educational Trade Publication. This site does not constitute medical, financial or legal advice. Note, An Interview/Story Is Not An Endorsement. It is intended for informational purposes only. It is not a substitute for professional medical advice, diagnosis or treatment. Never ignore professional medical advice in seeking treatment because of something you have read on the site. If you think you may have a medical emergency, immediately call your doctor or dial 911. Any use of this site constitutes your agreement to the Terms and Conditions and Privacy Policy. In no event is this information considered medical, legal, tax, financial, accounting or other professional advice (Please see full disclaimer below). This Podcast Is Subject to the Terms and Conditions of Use (https://conciergemedicinetoday.org/tcpp/) and is recorded/hosted by Concierge Medicine Today, LLC. Concierge Medicine Today, LLC., our representatives, agents or employees accept no responsibility or liability for direct, indirect, special, incidental or consequential damages or financial costs or claims made by the Physician(s) interviewed or our guests.

Next Post

(New) Ep 419 Medtail Expansion: The DocPreneur Leadership Podcast

Wed Jun 15 , 2022
By Concierge Medicine Today, […]